drugset / Trial / NCT00161980

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

NCT00161980 ↗

Phase 3 Completed Baxter Healthcare Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing the axillary lymphatics in subjects undergoing lumpectomy and level I and II axillary lymph node dissection with two separate incisions.

Timeline

Start
2001-06
Primary completion
—
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrin Sealant VH S/D Unknown — —